OncoGeneDx Custom Panel
New York
Approved
Conditions
- Colorectal Cancer
- Endometrial Cancer
- Familial Adenomatous Polyposis (FAP)
- Lynch Syndrome
- Ovarian Cancer
- Pancreatic Cancer
- Paraganglioma
- Pheochromocytoma
- Renal Cancer
- Attenuated Familial Adenomatous Polyposis (AFAP)
- Thyroid Cancer
- Brain Cancer
- Breast Cancer
Clinical Utility
- Identify the genetic basis of cancer for individuals who have features and/or a family history consistent with one of the hereditary cancer syndromes described above
- Determine appropriate clinical management recommendations based on a molecular diagnosis
- Identify family members at-risk to develop features associated with a specific hereditary cancer syndrome.
Lab Method
- Deletion/Duplication Analysis
- Next-Gen Sequencing
- MLPA
Test Code
B749
CPT Codes*
Varies by Gene
ABN Required
No
Turnaround Time**
21 days
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing